3.3 Emerging Infectious Pathogens and Clinical Preparedness

Emerging Diseases and Outbreak Preparedness

An emerging-pathogen plan should let a dental practice change screening, scheduling, source control, ventilation, PPE, cleaning, and staffing without improvising unsupported rules. The durable framework is the hierarchy of controls: eliminate or defer exposure when feasible, use engineering and administrative controls, then add PPE selected for the remaining hazard.

Keep Bloodborne Risk Current

Average occupational transmission estimates after percutaneous exposure to infected blood are approximately 0.2% for HCV and 0.23% for HIV. HBV risk can be substantially higher in a susceptible worker, especially when the source has high viral replication, but vaccination and documented anti-HBs response provide effective prevention.

After an exposure, wash or flush the site, report immediately, assess the source and exposure, and obtain confidential medical evaluation. There is no HCV postexposure prophylaxis; use baseline and follow-up testing. When HIV PEP is indicated, start a three-drug regimen as soon as possible, up to 72 hours after exposure, for 28 days. HBV management depends on the worker’s vaccine-response record and source HBsAg status. Do not transfer old percentages or schedules into a current protocol without checking CDC guidance.

Respiratory Outbreak Readiness

A novel or surging respiratory pathogen can change local transmission risk before dental-specific evidence is complete. The practice should monitor CDC, state, and local public-health guidance and define who activates enhanced measures. Key capabilities include:

• pre-appointment and arrival screening that can be updated quickly;
• nonpunitive sick-leave and occupational-health reporting;
• source-control supplies and a way to separate symptomatic people;
• knowledge of room ventilation and portable-air-cleaner capacity;
• adequate hand hygiene, disinfectants with the relevant EPA claim, and PPE inventory;
• a current respiratory-protection program for required respirator use; and
• referral arrangements when an AIIR or higher level of care is needed.

Avoid universal claims that every dental operatory must have one ACH or MERV rating. A ventilation professional assesses the existing HVAC system, room size, clean-air delivery, exhaust, and portable HEPA placement. Portable units are sized and positioned so they improve airflow rather than blow contaminated air across people.

Hierarchy of Controls

Elimination and Deferral

Postpone elective treatment for a patient who is currently infectious when delay is clinically safe. Use tele-triage, remote consultation, or medication management only within professional scope and clinical need. Emergency conditions—such as spreading infection threatening the airway, uncontrolled bleeding, or significant trauma—require prompt referral or treatment in an appropriate environment.

Engineering Controls

Use source-positioned high-volume evacuation, a dental dam when feasible, hands-free controls, barriers, and risk-assessed ventilation or HEPA filtration. HVE performance depends on actual flow, tip design, position, maintenance, and procedure; there is no universal 45-CFM or 98% capture guarantee. A dental dam can reduce saliva contamination for procedures on isolated teeth but does not protect against every aerosol source or respiratory emission.

Administrative Controls

Administrative measures include updated written procedures, staff training, vaccination consistent with current ACIP recommendations, scheduling to reduce contact, exposure reporting, adequate device inventory, and drills for a suspected case. An OSHA-required hepatitis B offer is distinct from a facility vaccine policy; do not label every recommended vaccine a federal mandate.

PPE

Select masks, respirators, eye/face protection, gloves, and clothing from the hazard assessment and current public-health guidance. When respiratory protection is required, use a NIOSH-approved respirator within an OSHA-compliant program that includes medical evaluation before use, annual fit testing for tight-fitting models, training, and a user seal check each time it is donned. Medical evaluation is not automatically repeated annually; reevaluation follows OSHA triggers.

Do not require an N95 for every routine aerosol-generating dental procedure solely because it generates aerosol. Respirator use depends on the infectious hazard, applicable guidance, and employer respiratory assessment. A surgical N95 supplies both particulate and fluid-resistance labeling; another respirator may need separate splash protection.

Resistant and Unusual Organisms

For an organism such as Candida auris, use the EPA list or label claim identified by current public-health guidance—EPA List P currently addresses C. auris—and follow the product’s contact time and surface restrictions. Do not assume an ordinary quaternary product is effective, and do not use a sporicidal claim as a universal shortcut without confirming the label.

For a novel pathogen, identify the transmission route, environmental persistence evidence, relevant EPA claims, and public-health case definition. Update policy when evidence changes. Preserve the date and source of each temporary protocol so obsolete emergency measures can be retired.

Continuity and Supply Planning

Maintain more than one vetted source for critical supplies, but verify NIOSH approval, FDA status, or EPA registration rather than accepting marketplace claims. Track respirator models and sizes because a substitute model requires fit testing. Rotate dated stock, protect it from heat and moisture, and document conservation strategies. Crisis-capacity reuse or extended use is not a routine standing policy; implement it only under current authoritative guidance and manufacturer limitations.

The exam-safe approach to an emerging event is: identify route → eliminate or defer exposure → add engineering and administrative controls → select PPE → verify the current source and date.